Can-Fite BioPharma 6-K Shows Co. Received Letter From Capital Point On Aug. 1, 2019 Requesting Co. Convene Shareholders Meeting To Amend Articles Of Association, Replace Board Members, Dismiss CEO
Benzinga Newsdesk